Evidence map›Paper›PMID 37818034›Full record

ReviewResearch (Washington, D.C.)2023

Customized Additive Manufacturing in Bone Scaffolds-The Gateway to Precise Bone Defect Treatment.

Juncen Zhou, Carmine Wang See, Sai Sreenivasamurthy, Donghui Zhu

Abstract readReview
In one paragraph

Review in Research (Washington, D.C.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Immune regulative GelMA&ZnBioactive materials · 2026
    Article
  10. Article
  11. Review
  12. Stem cells international · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juncen ZhouDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-7615-3543
Carmine Wang SeeDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-7380-3993
Sai SreenivasamurthyDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0003-1686-6805
Donghui ZhuDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-3057-1889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the advancing landscape of technology and novel material development, additive manufacturing (AM) is steadily making strides within the biomedical sector. Moving away from traditional, one-size-fits-all implant solutions, the advent of AM technology allows for patient-specific scaffolds that could improve integration and enhance wound healing. These scaffolds, meticulously designed with a myriad of geometries, mechanical properties, and biological responses, are made possible through the vast selection of materials and fabrication methods at our disposal. Recognizing the importance of precision in the treatment of bone defects, which display variability from macroscopic to microscopic scales in each case, a tailored treatment strategy is required. A patient-specific AM bone scaffold perfectly addresses this necessity. This review elucidates the pivotal role that customized AM bone scaffolds play in bone defect treatment, while offering comprehensive guidelines for their customization. This includes aspects such as bone defect imaging, material selection, topography design, and fabrication methodology. Additionally, we propose a cooperative model involving the patient, clinician, and engineer, thereby underscoring the interdisciplinary approach necessary for the effective design and clinical application of these customized AM bone scaffolds. This collaboration promises to usher in a new era of bioactive medical materials, responsive to individualized needs and capable of pushing boundaries in personalized medicine beyond those set by traditional medical materials.

Identifiers

PMID37818034
PMCPMC10561823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.